NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nicoya Lifesciences Inc.

Nicoya Lifesciences Inc.

Private
Kitchener, OntarioHealthcare & Life Scienceshttps://nicoyalife.com/

Last Round

Series A

Extension

Dec 16, 2021

Total Funding Raised

$30.57M

Company Overview

Nicoya Lifesciences Inc. is a life sciences tools company that provides advanced analytical instruments, using nanotechnology and microfluidics, for the biotechnology and pharmaceutical industries to accelerate drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

Surface Plasmon ResonanceSPRlabel-free analysisbiomolecular interaction analysisdrug discovery toolsbinding kineticsbiosensor technologyanalytical instrumentsbenchtop instrumentsdigital microfluidicsbiophysical characterizationlab automationinstrument consumablesprotein stability analysisprotein structure analysisbiologics engineeringcircular dichroismnanosensors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nicoya Lifesciences Inc. Comparables

Compare Nicoya Lifesciences Inc. with similar companies based on industry and business-model similarity.

Nicoya Lifesciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Nicoya Lifesciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 16, 2021
Series AJan 14, 2020
DebtMay 14, 2019
SeedJan 29, 2018

Key People

Founding team and executive leadership

Ryan Denomme

Founder And CEO

Founding Team

Colin Calvert

Chief Financial Officer

Executive Team

Nicoya Lifesciences Inc. Investors

Notable investors and investment history

Nicoya Lifesciences Inc. investors
InvestorRounds
Wilfrid Laurier UniversitySeries A, Seed
Maple Leaf AngelsSeed
University of Waterloo Student Venture FundSeries A, Seed
MaRS Discovery DistrictSeries A, Series A Extension, Seed
BDC CapitalDebt, Series A Extension, Seed
Innovation Grade VenturesSeed
Ripple VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2024

    Monthly visitors grew 78% MoM, reaching 25.5K.

  • Dec 16, 2021

    $16M round led by Whitecap Venture Partners

Nicoya Lifesciences Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nicoya Lifesciences Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nicoya Lifesciences Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKitchener, Ontario
Employee Range121
Year Founded2012
Last FundingDec 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.